220 related articles for article (PubMed ID: 11277393)
1. An effective strategy of using molecular testing to screen mentally retarded individuals for fragile X syndrome.
Tzeng CC; Lin SJ; Chen YJ; Kuo PL; Jong YJ; Tsai LP; Chen RM
Diagn Mol Pathol; 2001 Mar; 10(1):34-40. PubMed ID: 11277393
[TBL] [Abstract][Full Text] [Related]
2. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan.
Tzeng CC; Tzeng PY; Sun HS; Chen RM; Lin SJ
Diagn Mol Pathol; 2000 Jun; 9(2):75-80. PubMed ID: 10850542
[TBL] [Abstract][Full Text] [Related]
3. Feasibility of blood spot PCR in large-scale screening of fragile X syndrome in southern Taiwan.
Chow JC; Chen DJ; Lin CN; Chiu CY; Huang CB; Chiu PC; Lin CH; Lin SJ; Tzeng CC
J Formos Med Assoc; 2003 Jan; 102(1):12-6. PubMed ID: 12684606
[TBL] [Abstract][Full Text] [Related]
4. Pilot fragile X screening in normal population of Taiwan.
Tzeng CC; Cho WC; Kuo PL; Chen RM
Diagn Mol Pathol; 1999 Sep; 8(3):152-6. PubMed ID: 10565687
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype.
Tzeng CC; Tsai LP; Hwu WL; Lin SJ; Chao MC; Jong YJ; Chu SY; Chao WC; Lu CL
Am J Med Genet A; 2005 Feb; 133A(1):37-43. PubMed ID: 15637705
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic, carrier and prenatal genetic testing for fragile X syndrome and other FMR-1-related disorders in Johannesburg, South Africa: a 20-year review.
Essop FB; Krause A
S Afr Med J; 2013 Oct; 103(12 Suppl 1):994-8. PubMed ID: 24300646
[TBL] [Abstract][Full Text] [Related]
7. FMR1 gene mutations in patients with fragile X syndrome and obligate carriers: 30 years of experience in Chile.
Santa María L; Aliaga S; Faundes V; Morales P; Pugin Á; Curotto B; Soto P; Peña MI; Salas I; Alliende MA
Genet Res (Camb); 2016 Jun; 98():e11. PubMed ID: 27350105
[TBL] [Abstract][Full Text] [Related]
8. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
[TBL] [Abstract][Full Text] [Related]
9. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
[TBL] [Abstract][Full Text] [Related]
10. Molecular diagnosis of Fragile X syndrome in subjects with intellectual disability of unknown origin: implications of its prevalence in regional Pakistan.
Kanwal M; Alyas S; Afzal M; Mansoor A; Abbasi R; Tassone F; Malik S; Mazhar K
PLoS One; 2015; 10(4):e0122213. PubMed ID: 25875842
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Fragile-X Syndrome, 8p23.1 Deletion, and Balanced Translocation t(7;10)(p10;q24) in a Single Family.
Cortés H; Reyes-Rosales M; Rojas-Velasco AJ; García-Juárez B; Tapia-Guerrero YS; Arenas-Diaz S; Leyva-García N; Macías-Gallardo JJ; Carrillo-Mora P; Magaña JJ
Genet Test Mol Biomarkers; 2020 Aug; 24(8):527-531. PubMed ID: 32716213
[No Abstract] [Full Text] [Related]
12. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
[TBL] [Abstract][Full Text] [Related]
13. DNA testing for fragile X syndrome in 255 males from special schools in Singapore.
Tan BS; Law HY; Zhao Y; Yoon CS; Ng IS
Ann Acad Med Singap; 2000 Mar; 29(2):207-12. PubMed ID: 10895341
[TBL] [Abstract][Full Text] [Related]
14. An assessment of screening strategies for fragile X syndrome in the UK.
Pembrey ME; Barnicoat AJ; Carmichael B; Bobrow M; Turner G
Health Technol Assess; 2001; 5(7):1-95. PubMed ID: 11262423
[TBL] [Abstract][Full Text] [Related]
15. A step-wise diagnosis of fragile X syndrome in Taiwan.
Huang YT; Chiang SC; Tzeng CC; Liu CH; Chien YH; Hwu WL
Acta Paediatr Taiwan; 2004; 45(2):69-72. PubMed ID: 15335113
[TBL] [Abstract][Full Text] [Related]
16. Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.
Coffee B; Keith K; Albizua I; Malone T; Mowrey J; Sherman SL; Warren ST
Am J Hum Genet; 2009 Oct; 85(4):503-14. PubMed ID: 19804849
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
[TBL] [Abstract][Full Text] [Related]
18. A 15-year-long Southern blotting analysis of FMR1 to detect female carriers and for prenatal diagnosis of fragile X syndrome in Taiwan.
Tzeng CC; Tsai LP; Chang YK; Hung YJ; Chang YY; Su YP; Jiang JJ; Liang HM
Clin Genet; 2017 Aug; 92(2):217-220. PubMed ID: 28139839
[TBL] [Abstract][Full Text] [Related]
19. High-throughput analysis of fragile X (CGG)n alleles in the normal and premutation range by PCR amplification and automated capillary electrophoresis.
Larsen LA; Grønskov K; Nørgaard-Pedersen B; Brøndum-Nielsen K; Hasholt L; Vuust J
Hum Genet; 1997 Oct; 100(5-6):564-8. PubMed ID: 9341871
[TBL] [Abstract][Full Text] [Related]
20. Molecular screening for fragile X syndrome in mentally handicapped children in Korea.
Kwon SH; Lee KS; Hyun MC; Song KE; Kim JK
J Korean Med Sci; 2001 Jun; 16(3):271-5. PubMed ID: 11410685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
